FILE:LH/LH-8K-20041122093128.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
ITEM 7.01. Regulation FD Disclosure
On November 22, 2004  Laboratory Corporation of America Holdings (LabCorp) announced the availability of an innovative new chart-based laboratory order entry and results delivery system called . The product was developed in collaboration with one of LabCorp's strategic connectivity partners, Allscripts Healthcare Solutions, to help accelerate electronic medical record adoption by providing physician clients with a state-of-the-art connectivity solution that can be customized for their specific practices.
FirstChart
FirstChart
Exhibits
99.1 Press Release dated November 22, 2004
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit 99.1
Laboratory Corporation of America Holdings 358 South Main Street Burlington, NC 27215 Telephone:(336) 584-5171
FOR IMMEDIATE RELEASE Contact: Brad Hayes Shareholder Direct: (800)LAB-0401 Company Information: www.LabCorp.com
 Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) today announced the availability of an innovative new chart-based laboratory order entry and results delivery system called . The product was developed in collaboration with one of LabCorp's strategic connectivity partners, Allscripts Healthcare Solutions (Nasdaq: MDRX), to help accelerate electronic medical record adoption by providing physician clients with a state-of-the-art connectivity solution that can be customized for their specific practices.
Burlington, N.C., November 22, 2004
FirstChart
FirstChart
The product integrates LabCorp's unique and comprehensive laboratory processing abilities with Allscripts electronic medical record (EMR) technology, patient chart viewing and enhanced workflow capabilities. is designed to help LabCorp customers migrate toward the use of electronic medical record and other technology workflow solutions, such as e-prescribing and document imaging.
FirstChart
FirstChart
Also, as part of LabCorp's physician-focused connectivity strategy, the company has hired a team of experienced healthcare technology consultants to work daily with its national sales team to resolve the complex technology and connectivity issues often faced by physician offices.
"We are very excited about our expanded relationship with Allscripts Healthcare Solutions, as well as our joint involvement in the national movement to promote the use of electronic health records," said Bill Haas, LabCorp's executive vice president of sales and marketing. "LabCorp has an adaptable connectivity strategy that allows us to connect with our clients existing systems while maintaining the ability to accommodate future system updates. We recognize that clients need the ability to choose the systems that best meet their needs. By continuing to build relationships with the top healthcare technology vendors, we ensure LabCorp physician clients not only have access to the best technology, they also have choice."
"We are pleased that LabCorp will be including our software in its solution. As one of the nation's leading laboratory service providers, LabCorp's deployment of our software will help make Allscripts ubiquitous in physician practices," commented Glen Tullman, chairman and chief executive officer of Allscripts. "This new initiative reinforces LabCorp's healthcare IT leadership by helping physicians take important steps on the road toward the adoption of a complete electronic medical record."
FirstChart
Laboratory Corporation of America Holdings is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $2.9 billion in 2003, approximately 23,000 employees nationwide, and more than 220,000 clients, LabCorp offers over 4,400 clinical assays ranging from blood analyses to HIV and genomic testing. LabCorp combines its expertise in innovative clinical testing technology with its Centers of Excellence: The Center for Molecular Biology and Pathology, in Research Triangle Park, NC; National Genetics Institute, Inc. in Los Angeles, CA; ViroMed Laboratories, Inc. based in Minneapolis, MN; The Center for Esoteric Testing in Burlington, NC; and DIANON , Inc. based in Stratford, CT. LabCorp clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies. To learn more about our growing organization, visit our web site at: www.LabCorp.com.
About LabCorp
Systems
Allscripts Healthcare Solutions (AHS) is the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare. The Company's TouchWorks software is a modular Electronic Medical Record (EMR) that enhances physician productivity by automating the most common physician activities including prescribing, dictating, capturing charges, ordering labs and viewing results, providing patient education, and documenting clinical encounters. TouchWorks is available on the latest Tablet PCs, wireless handheld devices, desktop workstations and over the Internet. AHS also offers electronic document imaging and scanning solutions through its Advanced Imaging Concepts (AIC) subsidiary. Additionally, AHS provides healthcare product education and market research programs for physicians through its Physicians Interactive(tm) unit and medication fulfillment services through its Allscripts Direct(tm) unit. Visit AHS on the Web at . Strategic partners include IDX Systems, IMS Health, Microsoft, Hewlett-Packard Company, and Medco Health.
About Allscripts Healthcare Solutions
www.allscripts.com
Each of the above forward-looking statements is subject to change based on various important factors, including without limitation, competitive actions in the marketplace and adverse actions of governmental and other third-party payors. Actual results could differ materially from those suggested by these forward-looking statements. Further information on potential factors that could affect LabCorp's financial results is included in the Company's Form 10-K for the year ended December 31, 2003, and subsequent SEC filings.


